Chlor-dimethylaminosulfonium-Salze Darstellung und IR-Spektren

Chloro-dimethylaminosulfonium Salts. Preparation and I. R. Spectra By reaction of bis-dimethylamino-mono- resp. -disulfane with a mixture of chlorine/antimony(V) chloride the chloro dimethylaminosulfonium hexachloroantimonates(V) [(CH₃)₂N]₂SCI^⊕SbCl₆^? (I) and (CH₃)₂NSCI₂^⊕SbCl₆^? (II) are yielded. The i. r. spectra of these compounds were measured and assigned.     

Structural and magnetic properties of hexagonal perovskites La1.2Sr2.7MO7.33 (M = Ru, Ir) containing peroxide ions

The structures of the new compound La(1.2)Sr(2.7)IrO(7.33) and the recently discovered La(1.2)Sr(2.7)RuO(7.33) have been solved using a combination of X-ray and neutron diffraction. Both compounds crystallize in the trigonal space group Rm and consist of isolated MO6 (M = Ru, Ir) octahedra, which are arranged in well-defined hexagonal perovskite slabs. These slabs are separated by (Sr2O(1+delta)) layers containing both O2- and (O2)2- ions. The composition can therefore be written as La(1.2)Sr(2.7)MO(7-delta)(O2)delta with delta = 0.33. Results of the magnetic susceptibility and XANES measurements show that the transition metal cations are in a pentavalent state. While in La(1.2)Sr(2.7)RuO(7.33) an antiferromagnetic interaction between the Ru5+ ions is found, La(1.2)Sr(2.7)IrO(7.33) shows a very small temperature-independent paramagnetism down to 1.8 K due to the strong spin-orbit coupling characteristic for the 5d element iridium.     

Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization

A liquid chromatographic/mass spectrometric assay with atmospheric pressure chemical ionization (LC/APCI-MS) is presented for fast and reliable screening and identification and also for precise and sensitive quantification in plasma of the 23 benzodiazepines alprazolam, bromazepam, brotizolam, camazepam, chlordiazepoxide, clobazam, clonazepam, diazepam, flunitrazepam, flurazepam, desalkylflurazepam, lorazepam, lormetazepam, medazepam, metaclazepam, midazolam, nitrazepam, nordazepam, oxazepam, prazepam, temazepam and tetrazepam, triazolam, their antagonist flumazenil and the benzodiazepine BZ1 (omega 1) receptor agonists zaleplone, zolpidem and zopiclone. It allows confirmation of the diagnosis of an overdose situation and monitoring of psychiatric patients' compliance. The analytes were isolated from plasma using liquid-liquid extraction and were separated on a Merck LiChroCART column with Superspher 60 RP Select B as the stationary phase. Gradient elution was performed using aqueous ammonium formate and acetonitrile. After screening and identification in the scan mode using the authors' LC/MS library, the analytes were quantified in the selected-ion monitoring mode. The quantification assay was fully validated. It was found to be selective proved to be linear from sub-therapeutic to over therapeutic concentrations for all analytes, except bromazepam. The corresponding reference levels the assay's accuracy and precision data for all studied substances are listed. The accuracy and precision data were within the required limits with the exception of those for bromazepam. The analytes were stable in frozen plasma for at least 1 month. The validated assay was successfully applied to several authentic plasma samples from patients treated or intoxicated with various benzodiazepines or with zaleplone, zolpidem or zopiclone. It has proven to be appropriate for the isolation, separation, screening, identification and quantification of the drugs mentioned above in plasma for clinical toxicology, e.g. in cases of poisoning, and forensic toxicology, e.g. in cases of driving under the influence of drugs.     

Reaktionsprodukte aus Antimon(V)-chlorid und N,N′-Dimethyloxamid und deren Schwingungsspektren

Reaction Products of Antimony(V) Chloride and N, N′-Dimethyloxamide and their Vibrational Spectra N, N′-Dimethyloxamide reacts with antimony(V) chloride at lower temperatures to the 1:1 resp. 1:2 addition compounds I resp. II. Pyrolysis of these compounds leads to the cyclic tetrachloroantimony(V)-N, N′-dimethyloxamides (III) resp.(V). III yields with antimony(V) chloride the 1:1 adduct IV, which is transformed to V. The vibrational spectra were assigned and discussed.     

Screening,library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization

A liquid chromatographic/mass spectrometric assay with atmospheric pressure chemical ionization (APCI-LC/MS) is presented for the fast and reliable screening and identification and for the precise and sensitive quantification of 15 neuroleptic (antipsychotic) drugs and three of their relevant metabolites in plasma. It allows confirmation of the diagnosis of a neuroleptic overdose and monitoring of psychiatric patients' compliance. The neuroleptics amisulpride, bromperidol, clozapine, droperidol, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perazine, pimozide, risperidone, sulpiride, zotepine and zuclopenthixol and the pharmacologically active metabolites norclozapine, clozapine N-oxide and 9-hydroxyrisperidone were extracted from plasma using solid-phase extraction and were separated on a Merck LiChroCART column with Superspher 60 RP Select B as the stationary phase. Gradient elution was performed using aqueous ammonium formate and acetonitrile. After screening and identification in the scan mode using the authors' new LC/MS library, the neuroleptics were quantified in the selected-ion mode. The quantification assay was fully validated. It was found to be selective and proved to be linear from sub-therapeutic to over therapeutic concentrations for all analytes. The corresponding reference levels are listed. The accuracy and precision data were within the required limits. The analytes were stable in frozen plasma for at least 1 month. The method was successfully applied to several authentic plasma samples from patients treated or intoxicated with various neuroleptics. The validated LC/MS assay has proved to be appropriate for the isolation, separation, screening, identification and quantification of various neuroleptics in plasma for clinical toxicology and therapeutic drug monitoring purposes.